Overview

Hypoxia Imaging With 18F FAZA. Prognostic Impact in Cervical Cancer

Status:
Unknown status
Trial end date:
2007-07-01
Target enrollment:
0
Participant gender:
Female
Summary
The aim of this study is to visualize the tumor hypoxic tissue, the potential quantitative changes and the biological behavior of cervical carcinoma (primary and / or lymph nodes) before, during and after radiochemotherapy with the novel hypoxia PET tracer 18FAZA.
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Medical University of Vienna
Treatments:
Fluoroazomycin arabinoside
Criteria
Inclusion Criteria:

- First diagnosis of histologically proven cervical cancer FIGO stage IB2 to IVA.

- Treatment intention for the purpose of achieving cure

- Age < 80 years

- No previous standard or radical hysterectomy

Exclusion Criteria:

- Pregnancy, breast-feeding women, patients that are not able to lie motionless for one
hour.Palliative treatment, recurrent disease, neoadjuvant chemotherapy, other
pre-existing malignancies, age > 80 years,